
|Videos|March 29, 2016
Advantages of Novel Oral Anticoagulants Over Vitamin K Antagonists
John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about the advantage of novel oral anticoagulants over vitamin K antagonists.
Advertisement
John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about the advantage of novel oral anticoagulants over vitamin K antagonists.
This video was recorded at APhA's 2016 Annual Meeting and Exposition in Baltimore, Maryland.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Lynkuet Access Program Aims to Help Women Save on Neurokinin-Targeted Therapy
2
Fall 2025 Quiz: Test Your Pharmacy Knowledge!
3
Hormone Therapy Use, Understanding, and Perceptions Have Positively Shifted From 2021 to 2025
4
New Data Show Elinzanetant Is a Safe, Well-Tolerated Non-Hormonal Therapy for Menopausal Vasomotor Symptoms
5














































































































































































































